<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

News and Stories

Press Releases (3)

Research    Press Releases

Anxiety Among Fathers Is Higher Than Recently Reported, New Study Suggests

New research suggests anxiety among men transitioning into parenthood is significantly higher than reported by the global World Health Organization (WHO) regional prevalence rates.


Author Julia Milzer | Publish Date
Full Story

Research    Press Releases

OCD Patients With Comorbidities Respond Well to Deep Brain Stimulation

A new study published in Frontiers in Psychiatry finds that patients with Obsessive Compulsive Disorder (OCD) as well as other psychiatric comorbidities, such as autism spectrum or tic disorders, may respond well to Deep Brain Stimulation (DBS).


Author Kelsea Pieters | Publish Date
Full Story

Research    Press Releases

One in Five Colorado High School Students Has Access to Firearms

Twenty percent of high school students have easy access to a handgun, according to a new study from the Colorado School of Public Health on the University of Colorado Anschutz Medical Campus.

In the study published today in The Journal of Pediatrics, the researchers examined the prevalence of handgun access among adolescents in Colorado and explored individual and geographic characteristics, as well as related health factors.

“Our findings highlight that it is relatively easy to access a handgun in Colorado for high school students. This finding, combined with the high prevalence of feeling sad or depressed and suicide attempts, is concerning for the safety of adolescents,” said lead author Ashley Brooks-Russell, PhD, MPH, assistant professor in the Colorado School of Public Health.


Author Julia Milzer | Publish Date
Full Story

Research    Press Releases   

Alzheimer’s Patients’ Cognition Improves With Sargramostim, New Study Shows

A new study suggests that Sargramostim, a medication often used to boost white blood cells after cancer treatments, is also effective in treating and improving memory in people with mild-to-moderate Alzheimer's disease. This medication comprises of a natural human protein produced by recombinant DNA technology (yeast-derived rhu GM-CSF/Leukine®).


Author Julia Milzer | Publish Date
Full Story